Biotechnology Industry Organization President and CEO Jim Greenwood reflects on the trade group's legislative priorities in 2007 as the new Democratic-controlled Congress gets to work. Greenwood joined BIO in January 2005 after 12 years in Congress as a Republican Representative from the 8 district of Pennsylvania. In Congress, he served as chairman of the Energy and Commerce Committees Subcommittee on Oversight and Investigations, where he led a review of drug reimbursement issues and contributed to the passage of the Medicare Modernization Act of 2003.
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?